# A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation

> **NCT07342205** · PHASE2,PHASE3 · RECRUITING · sponsor: **Shanghai University of Traditional Chinese Medicine** · enrollment: 60 (estimated)

## Conditions studied

- Acute Respiratory Distress Syndrome (ARDS)
- Acute Lung Injury(ALI)
- Sepsis Related Acute Lung Injury/Acute Respiratory Distress Syndrome

## Interventions

- **OTHER:** Placebo control group
- **OTHER:** Human-derived active intestinal bacterial liquid group

## Key facts

- **NCT ID:** NCT07342205
- **Lead sponsor:** Shanghai University of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-10
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07342205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07342205, "A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07342205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*